Results 111 to 120 of about 3,822 (305)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Random forest automated supervised classification of Hipparcos periodic variable stars

open access: yes, 2016
We present an evaluation of the performance of an automated classification of the Hipparcos periodic variable stars into 26 types. The sub-sample with the most reliable variability types available in the literature is used to train supervised algorithms ...
L. Eyer   +31 more
core  

Characterization of variable stars by robust wave variograms: An application to Hipparcos mission

open access: yes, 1999
Variogram analysis is applied to time series of variable stars. This method allows to characterize time-scales of varying signals. It is well suited for periodic and pseudo-periodic signals. The aspects of robustness, bin positions and bin widths for the
L. Eyer, M. G. Genton
core   +1 more source

Revisiting γ-ray Orbital Modulation in the Redback Millisecond Pulsar PSR J2039−5617

open access: yesThe Astrophysical Journal
PSR J2039−5617 is a redback millisecond pulsar binary system consisting of a compact star with a mass of 1.1–1.6 M _⊙ and a low-mass companion of 0.15–0.22 M _⊙ .
Mengqing Zhang   +3 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

HAT discovery of 76 bright periodic variable stars toward the Galactic bulge

open access: yes, 2016
We report on photometric I-band observations of 147 bright (8 < I < 13) periodic variable stars toward the Galactic bulge including 76 new discoveries. We used one of the HATnet telescopes to obtain 151 exposures spanning 88 nights in 2005 of an 8.°4
Nataf, David, Bakos, Gaspar, Stanek, K Z
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Near Continuous Photometry with the Whole Earth Telescope (WET)

open access: yesOpen Astronomy, 2003
The Whole Earth Telescope (WET) saw first light in 1988. It was invented by scientists from the Astronomy Department, University of Texas at Austin.
Solheim J. E.
doaj   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

open access: yesMolecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski   +10 more
wiley   +1 more source

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

open access: yesFEBS Open Bio, EarlyView.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy